Aranding, Jaren Mae J.
HRN: 25-63-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2024
CEFAZOLIN 1GM (VIAL)
08/09/2024
08/16/2024
INTRAVENOUS
467 Mg
Every 8 Hours
To Consider Folliculitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes